Trek Diagnostic Systems opens new U.K. manufacturing and research plant

Cleveland-based Trek opened the facility to meet increasing demand for its microbiology testing kits.

Image by estherase via Flickr

CLEVELAND, Ohio — Trek Diagnostic Systems, which makes microbiology test kits used by diagnostic labs, has opened a new manufacturing and research facility in the United Kingdom.

Trek, which was acquired in 2006 by Boston-based Magellan Biosciences, opened the new plant to “meet increasing global demand” for its Sensitire product line of “susceptibility plates,” according to a statement from the company.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

The plates are used to determine the appropriate drug and dosage levels required to treat bacterial and yeast infections.

“We outgrew our previous facility thanks to increasing demand for our expanding line of susceptibility products, which provide our customers with the cost-effective and reliable microbiology results they need to make more-informed treatment decisions,” said James Whelan, president of Magellan Clinical Diagnostics.